Go here to opt-out of our email list or mark as SPAM .
Please add us to your address book or whitelist us. Directions for whitelisting are here.
Revolutionary gene therapy for hemophilia B receives Health Canada Authorization
In a groundbreaking development, a revolutionary gene therapy for Hemophilia B has received authorization from Health Canada. This significant milestone offers new hope to individuals living with Hemophilia B in Canada and represents a major advancement in the field of medical treatment.
Hemophilia B is a rare and inherited bleeding disorder, and traditional treatment often requires frequent infusions of clotting factor.
Read More >>
THIS WEEK'S TOP STORIES ...
US health officials prioritize RSV shots for at-risk infants amid supply shortages
Israeli Mental Health Crisis Deepens Following October Attack: WHO Reports
Sand flies transmit new strain of Leishmaniasis in US
~Body Boosters
You opted in to receive these emails when you requested information or entered one of our contests. You can Manage Subcription here if you do not want to receive these emails any longer. To help make sure we make it into your inbox, add [email protected] to your address book.
|
